More articles from Oncology - Basic: Basic Science

You have access
Synergistic effect of Taxol and enhanced delivery effect of pulsed high intensity focused ultrasound (P-HIFU) when combined with radioimmunotherapy
Beom Jang, In Shin, Zhengsheng Yao, Hilary Hancock, Hyung Kim, Matthew Dreher, Brad Wood, Victor Frenkel, Ira Pastan and Chang Paik

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 503;
You have access
Prediction of early antiproliferative response to anti-VEGF monoclonal antibody molecular-targeting therapy (bevacizumab) in human tumor xenograft using FLT
Songji Zhao, Yuji Kuge, Yan Zhao, Satoshi Takeuchi, Yongnan Jin, Toshiyuki Hatano, Ichiro Kinoshita, Hirotoshi Dosaka-Akita and Nagara Tamaki

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 449;
You have access
PET imaging of EGFR antibody distribution in head-neck squamous cell carcinoma models
Gang Niu, Zibo Li, Jin Xie, Quynh-Thu Le and Xiaoyuan (Shawn) Chen

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 454;
You have access
Targeted radiotherapy of integrin αvβ3-positive tumors with 90Y-labeled RGD tetramer
Bing Jia, Zilin Yu, Zhaofei Liu, Jiyun Shi, Huiyun Zhao, Xiaoyuan (Shawn) Chen and Fan Wang

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 507;
You have access
Imaging CXCR4 expression in orthotopic and metastatic models of breast cancer
Sridhar Nimmagadda, Mrudula Pullambhatla, James Fox, Gilbert Green and Martin Pomper

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 384;
You have access
A novel approach to pre-targeted radioimmunotherapy that uses DOTA as the radionuclide-carrying hapten
Kelly Davis, Preeti Misra, Adrian Slusarczyk, Maryelise Cieslewicz, Benjamin Ruiz-Yi, Kumar Bhushan, John Frangioni and Karl Wittrup

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 506;
You have access
Anti-CD20 diabodies for targeting and imaging lymphoma
Tove Olafsen, Shannon Sirk, David Betting, Vania Kenanova, Andrew Raubitschek, John Timmerman and Anna Wu

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 383;
You have access
Tumor FDG uptake as biomarker for defining the optimal biological dose of the mTOR inhibitor everolimus
C. Kuntner, Daniel Cejka, T. Wanek, Maria Zsebedics, Markus Mueller, Volker Wacheck and Oliver Langer

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 452;
You have access
Evaluation of tumor response to the antivascular agent DMXAA using 18F-FMISO PET
Christoph Oehler-Janne, Joseph O'Donoghue, C.Clifton Ling and Sean Carlin

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 451;
You have access
Radioimmunotherapy of small peritoneal carcinomatosis using 125I-labeled monoclonal antibodies
Jean-Pierre Pouget, Lore Santoro, Berengere Piron, Samir Boutaleb, Caroline Bascoul-Mollevi, Manuel Bardies, Pierre-Olivier Kotzki, Monique Pelegrin and Andre Pelegrin

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 505;

Main menu

User menu

Search

More articles from Oncology - Basic: Basic Science

Pages